RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $909.000 thousand which beat the analyst consensus estimate of $716.500 thousand by 26.87 percent. This is a 115.40 percent increase over sales of $422.000 thousand the same period last year.